Cardiovascular magnetic resonance imaging in ischemic heart disease

Journal of Magnetic Resonance Imaging

Volumn 36, Issue 1, 2012, Pages 20-38

  Von Knobelsdorff Brenkenhoff, Florian ^a,b   Schulz Menger, Jeanette ^a,b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b HELIOS KLINIKUM BERLIN BUCH   (Germany)

Author keywords

acute coronary syndrome; chronic coronary artery disease; magnetic resonance; stress test

Indexed keywords

DOBUTAMINE; GADOLINIUM;

ACUTE DISEASE; ARTERIAL WALL THICKNESS; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; ECHOCARDIOGRAPHY; EXERCISE TEST; HEART INFARCTION SIZE; HEART MOVEMENT; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; NONHUMAN; NUCLEAR MEDICINE; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

CORONARY ARTERY DISEASE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING, CINE; MYOCARDIAL ISCHEMIA; MYOCARDIAL PERFUSION IMAGING;

EID: 84862736475     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23580     Document Type: Review

References (150)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011; 123: e18-e209.
2. Bonow RO,. Clinical practice. Should coronary calcium screening be used in cardiovascular prevention strategies? N Engl J Med 2009; 361: 990-997.
3. Hundley WG, Bluemke DA, Finn JP, et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation 2010; 121: 2462-2508.
4. Beek AM, van Rossum AC,. Cardiovascular magnetic resonance imaging in patients with acute myocardial infarction. Heart 2010; 96: 237-243.
5. Karamitsos TD, Dall'Armellina E, Choudhury RP, Neubauer S,. Ischemic heart disease: comprehensive evaluation by cardiovascular magnetic resonance. Am Heart J 2011; 162: 16-30.
6. Bruder O, Schneider S, Nothnagel D, et al. EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase. J Am Coll Cardiol 2009; 54: 1457-1466.
7. Charoenpanichkit C, Hundley WG,. The 20 year evolution of dobutamine stress cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2010; 12: 59.
8. Gerber BL, Raman SV, Nayak K, et al. Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. J Cardiovasc Magn Reson 2008; 10: 18.
9. Kim HW, Farzaneh-Far A, Kim RJ,. Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications. J Am Coll Cardiol 2009; 55: 1-16.
10. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 2002; 106: 1883-1892.
11. Gould KL,. Does coronary flow trump coronary anatomy? JACC Cardiovasc Imaging 2009; 2: 1009-1023.
12. Panting JR, Gatehouse PD, Yang GZ, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002; 346: 1948-1953. (Pubitemid 34651354)
13. Vogel-Claussen J, Skrok J, Dombroski D, et al. Comprehensive adenosine stress perfusion MRI defines the etiology of chest pain in the emergency room: comparison with nuclear stress test. J Magn Reson Imaging 2009; 30: 753-762.
14. Petersen SE, Jerosch-Herold M, Hudsmith LE, et al. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 2007; 115: 2418-2425. (Pubitemid 46717964)
15. Pennell DJ, Underwood SR, Manzara CC, et al. Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol 1992; 70: 34-40.
16. Mandapaka S, Hundley WG,. Dobutamine cardiovascular magnetic resonance: a review. J Magn Reson Imaging 2006; 24: 499-512. (Pubitemid 44320551)
17. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002; 105: 539-542. (Pubitemid 34262671)
18. Wahl A, Paetsch I, Gollesch A, et al. Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia: experience in 1000 consecutive cases. Eur Heart J 2004; 25: 1230-1236. (Pubitemid 38891573)
19. Kuijpers D, Janssen CH, van Dijkman PR, Oudkerk M,. Dobutamine stress MRI. Part I. Safety and feasibility of dobutamine cardiovascular magnetic resonance in patients suspected of myocardial ischemia. Eur Radiol 2004; 14: 1823-1828. (Pubitemid 39386631)
20. Geleijnse ML, Krenning BJ, Nemes A, et al. Incidence, pathophysiology, and treatment of complications during dobutamine-atropine stress echocardiography. Circulation 2010; 121: 1756-1767.
21. Nagel E, Lehmkuhl HB, Bocksch W, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999; 99: 763-770. (Pubitemid 29083016)
22. Hundley WG, Hamilton CA, Thomas MS, et al. Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 1999; 100: 1697-1702. (Pubitemid 29485251)
23. Nandalur KR, Dwamena BA, Choudhri AF, Nandalur MR, Carlos RC,. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol 2007; 50: 1343-1353. (Pubitemid 47449733)
24. Wahl A, Paetsch I, Roethemeyer S, Klein C, Fleck E, Nagel E,. High-dose dobutamine-atropine stress cardiovascular MR imaging after coronary revascularization in patients with wall motion abnormalities at rest. Radiology 2004; 233: 210-216. (Pubitemid 39280976)
25. Syed MA, Paterson DI, Ingkanisorn WP, et al. Reproducibility and inter-observer variability of dobutamine stress CMR in patients with severe coronary disease: implications for clinical research. J Cardiovasc Magn Reson 2005; 7: 763-768. (Pubitemid 41770053)
26. Paetsch I, Jahnke C, Ferrari VA, et al. Determination of interobserver variability for identifying inducible left ventricular wall motion abnormalities during dobutamine stress magnetic resonance imaging. Eur Heart J 2006; 27: 1459-1464. (Pubitemid 43998080)
27. Lubbers DD, Janssen CH, Kuijpers D, et al. The additional value of first pass myocardial perfusion imaging during peak dose of dobutamine stress cardiac MRI for the detection of myocardial ischemia. Int J Cardiovasc Imaging 2008; 24: 69-76. (Pubitemid 350263106)
28. Gebker R, Jahnke C, Manka R, et al. Additional value of myocardial perfusion imaging during dobutamine stress magnetic resonance for the assessment of coronary artery disease. Circ Cardiovasc Imaging 2008; 1: 122-130.
29. Gebker R, Mirelis JG, Jahnke C, et al. Influence of left ventricular hypertrophy and geometry on diagnostic accuracy of wall motion and perfusion magnetic resonance during dobutamine stress. Circ Cardiovasc Imaging 2010; 3: 507-514.
30. Kuijpers D, Ho KY, van Dijkman PR, Vliegenthart R, Oudkerk M,. Dobutamine cardiovascular magnetic resonance for the detection of myocardial ischemia with the use of myocardial tagging. Circulation 2003; 107: 1592-1597. (Pubitemid 36397326)
31. Paetsch I, Foll D, Kaluza A, et al. Magnetic resonance stress tagging in ischemic heart disease. Am J Physiol Heart Circ Physiol 2005; 288: H2708-H2714. (Pubitemid 40720649)
32. Korosoglou G, Lossnitzer D, Schellberg D, et al. Strain-encoded cardiac MRI as an adjunct for dobutamine stress testing: incremental value to conventional wall motion analysis. Circ Cardiovasc Imaging 2009; 2: 132-140.
33. Kelle S, Hamdan A, Schnackenburg B, et al. Dobutamine stress cardiovascular magnetic resonance at 3 Tesla. J Cardiovasc Magn Reson 2008; 10: 44.
34. Hundley WG, Morgan TM, Neagle CM, Hamilton CA, Rerkpattanapipat P, Link KM,. Magnetic resonance imaging determination of cardiac prognosis. Circulation 2002; 106: 2328-2333. (Pubitemid 35244733)
35. Kuijpers D, van Dijkman PR, Janssen CH, Vliegenthart R, Zijlstra F, Oudkerk M,. Dobutamine stress MRI. Part II. Risk stratification with dobutamine cardiovascular magnetic resonance in patients suspected of myocardial ischemia. Eur Radiol 2004; 14: 2046-2052. (Pubitemid 39481175)
36. Jahnke C, Nagel E, Gebker R, et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 2007; 115: 1769-1776. (Pubitemid 46648614)
37. Kelle S, Chiribiri A, Vierecke J, et al. Long-term prognostic value of dobutamine stress CMR. JACC Cardiovasc Imaging 2011; 4: 161-172.
38. Atkinson DJ, Burstein D, Edelman RR,. First-pass cardiac perfusion: evaluation with ultrafast MR imaging. Radiology 1990; 174: 757-762. (Pubitemid 20089667)
39. Gerber TC, Carr JJ, Arai AE, et al. Ionizing radiation in cardiac imaging: a science advisory from the American Heart Association Committee on Cardiac Imaging of the Council on Clinical Cardiology and Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention. Circulation 2009; 119: 1056-1065.
40. Kellman P, Arai AE,. Imaging sequences for first pass perfusion-a review. J Cardiovasc Magn Reson 2007; 9: 525-537. (Pubitemid 46399023)
41. Iskandrian AE, Bateman TM, Belardinelli L, et al. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol 2007; 14: 645-658. (Pubitemid 47355078)
42. Manka R, Jahnke C, Kozerke S, et al. Dynamic 3-dimensional stress cardiac magnetic resonance perfusion imaging detection of coronary artery disease and volumetry of myocardial hypoenhancement before and after coronary stenting. J Am Coll Cardiol 2011; 57: 437-444.
43. Ishida N, Sakuma H, Motoyasu M, et al. Noninfarcted myocardium: correlation between dynamic first-pass contrast-enhanced myocardial MR imaging and quantitative coronary angiography. Radiology 2003; 229: 209-216. (Pubitemid 37152126)
44. Schwitter J, Wacker CM, van Rossum AC, et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 2008; 29: 480-489. (Pubitemid 351264187)
45. Yong AS, Ng AC, Brieger D, Lowe HC, Ng MK, Kritharides L,. Three-dimensional and two-dimensional quantitative coronary angiography, and their prediction of reduced fractional flow reserve. Eur Heart J 2011; 32: 345-353.
46. Costa MA, Shoemaker S, Futamatsu H, et al. Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic coronary artery disease as measured by coronary angiography and fractional flow reserve. J Am Coll Cardiol 2007; 50: 514-522. (Pubitemid 47126780)
47. Watkins S, McGeoch R, Lyne J, et al. Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease. Circulation 2009; 120: 2207-2213.
48. Lockie T, Ishida M, Perera D, et al. High-resolution magnetic resonance myocardial perfusion imaging at 3.0-Tesla to detect hemodynamically significant coronary stenoses as determined by fractional flow reserve. J Am Coll Cardiol 2010; 57: 70-75.
49. Klein C, Nagel E, Gebker R, et al. Magnetic resonance adenosine perfusion imaging in patients after coronary artery bypass graft surgery. JACC Cardiovasc Imaging 2009; 2: 437-445.
50. Bernhardt P, Spiess J, Levenson B, et al. Combined assessment of myocardial perfusion and late gadolinium enhancement in patients after percutaneous coronary intervention or bypass grafts: a multicenter study of an integrated cardiovascular magnetic resonance protocol. JACC Cardiovasc Imaging 2009; 2: 1292-1300.
51. Karamitsos TD, Arnold JR, Pegg TJ, et al. Tolerance and safety of adenosine stress perfusion cardiovascular magnetic resonance imaging in patients with severe coronary artery disease. Int J Cardiovasc Imaging 2009; 25: 277-283.
52. Jerosch-Herold M,. Quantification of myocardial perfusion by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2010; 12: 57.
53. Utz W, Greiser A, Niendorf T, Dietz R, Schulz-Menger J,. Single- or dual-bolus approach for the assessment of myocardial perfusion reserve in quantitative MR perfusion imaging. Magn Reson Med 2008; 59: 1373-1377. (Pubitemid 351813267)
54. Patel AR, Antkowiak PF, Nandalur KR, et al. Assessment of advanced coronary artery disease: advantages of quantitative cardiac magnetic resonance perfusion analysis. J Am Coll Cardiol 2010; 56: 561-569.
55. Araoz PA, Glockner JF, McGee KP, et al. 3 Tesla MR imaging provides improved contrast in first-pass myocardial perfusion imaging over a range of gadolinium doses. J Cardiovasc Magn Reson 2005; 7: 559-564. (Pubitemid 40770333)
56. Cheng AS, Pegg TJ, Karamitsos TD, et al. Cardiovascular magnetic resonance perfusion imaging at 3-tesla for the detection of coronary artery disease: a comparison with 1.5-tesla. J Am Coll Cardiol 2007; 49: 2440-2449. (Pubitemid 46962268)
57. Plein S, Schwitter J, Suerder D, Greenwood JP, Boesiger P, Kozerke S,. k-Space and time sensitivity encoding-accelerated myocardial perfusion MR imaging at 3.0 T: comparison with 1.5 T. Radiology 2008; 249: 493-500.
58. Plein S, Kozerke S, Suerder D, et al. High spatial resolution myocardial perfusion cardiac magnetic resonance for the detection of coronary artery disease. Eur Heart J 2008; 29: 2148-2155.
59. Steel K, Broderick R, Gandla V, et al. Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease. Circulation 2009; 120: 1390-1400.
60. Ingkanisorn WP, Kwong RY, Bohme NS, et al. Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol 2006; 47: 1427-1432.
61. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003; 361: 374-379. (Pubitemid 36164969)
62. Kim RJ, Albert TS, Wible JH, et al. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Circulation 2008; 117: 629-637.
63. Klem I, Heitner JF, Shah DJ, et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol 2006; 47: 1630-1638.
64. Cury RC, Shash K, Nagurney JT, et al. Cardiac magnetic resonance with T2-weighted imaging improves detection of patients with acute coronary syndrome in the emergency department. Circulation 2008; 118: 837-844.
65. Friedrich MG,. Myocardial edema-a new clinical entity? Nat Rev Cardiol 2010; 7: 292-296.
66. McNamara MT, Higgins CB, Ehman RL, Revel D, Sievers R, Brasch RC,. Acute myocardial ischemia: magnetic resonance contrast enhancement with gadolinium-DTPA. Radiology 1984; 153: 157-163. (Pubitemid 14043401)
67. Eichstaedt HW, Felix R, Dougherty FC, Langer M, Rutsch W, Schmutzler H,. Magnetic resonance imaging (MRI) in different stages of myocardial infarction using the contrast agent gadolinium-DTPA. Clin Cardiol 1986; 9: 527-535. (Pubitemid 17178020)
68. Kim RJ, Chen EL, Lima JA, Judd RM,. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996; 94: 3318-3326. (Pubitemid 26427504)
69. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100: 1992-2002. (Pubitemid 29529292)
70. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001; 218: 215-223. (Pubitemid 32151298)
71. Kino A, Zuehlsdorff S, Sheehan JJ, et al. Three-dimensional phase-sensitive inversion-recovery turbo FLASH sequence for the evaluation of left ventricular myocardial scar. AJR Am J Roentgenol 2009; 193: W381-W388.
72. Ledesma-Carbayo MJ, Kellman P, Hsu LY, Arai AE, McVeigh ER,. Motion corrected free-breathing delayed-enhancement imaging of myocardial infarction using nonrigid registration. J Magn Reson Imaging 2007; 26: 184-190. (Pubitemid 47235249)
73. Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA,. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 2011; 57: 891-903.
74. Ibrahim T, Bulow HP, Hackl T, et al. Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction. J Am Coll Cardiol 2007; 49: 208-216. (Pubitemid 46054392)
75. Klein C, Nekolla SG, Bengel FM, et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002; 105: 162-167. (Pubitemid 34084313)
76. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB,. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977; 56: 786-794. (Pubitemid 8235183)
77. Abdel-Aty H, Boye P, Zagrosek A, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 2005; 45: 1815-1822. (Pubitemid 40779862)
78. Bohl S, Wassmuth R, Abdel-Aty H, et al. Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease. Int J Cardiovasc Imaging 2008; 24: 597-607.
79. Mahrholdt H, Wagner A, Parker M, et al. Relationship of contractile function to transmural extent of infarction in patients with chronic coronary artery disease. J Am Coll Cardiol 2003; 42: 505-512. (Pubitemid 36951719)
80. Kwong RY, Chan AK, Brown KA, et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006; 113: 2733-2743. (Pubitemid 43947991)
81. Ricciardi MJ, Wu E, Davidson CJ, et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 2001; 103: 2780-2783. (Pubitemid 32550063)
82. Kumar A, Abdel-Aty H, Kriedemann I, et al. Contrast-enhanced cardiovascular magnetic resonance imaging of right ventricular infarction. J Am Coll Cardiol 2006; 48: 1969-1976. (Pubitemid 44767976)
83. Larose E, Ganz P, Reynolds HG, et al. Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction. J Am Coll Cardiol 2007; 49: 855-862.
84. Tanimoto T, Imanishi T, Kitabata H, et al. Prevalence and clinical significance of papillary muscle infarction detected by late gadolinium-enhanced magnetic resonance imaging in patients with ST-segment elevation myocardial infarction. Circulation 2010; 122: 2281-2287.
85. Okayama S, Uemura S, Soeda T, et al. Clinical significance of papillary muscle late enhancement detected via cardiac magnetic resonance imaging in patients with single old myocardial infarction. Int J Cardiol 2011; 146: 73-79.
86. Thiele H, Kappl MJ, Conradi S, Niebauer J, Hambrecht R, Schuler G,. Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging. J Am Coll Cardiol 2006; 47: 1641-1645.
87. Kellman P, Hernando D, Shah S, et al. Multiecho dixon fat and water separation method for detecting fibrofatty infiltration in the myocardium. Magn Reson Med 2009; 61: 215-221.
88. Goldfarb JW, Roth M, Han J,. Myocardial fat deposition after left ventricular myocardial infarction: assessment by using MR water-fat separation imaging. Radiology 2009; 253: 65-73.
89. Lockie T, Nagel E, Redwood S, Plein S,. Use of cardiovascular magnetic resonance imaging in acute coronary syndromes. Circulation 2009; 119: 1671-1681.
90. Flett AS, Westwood MA, Davies LC, Mathur A, Moon JC,. The prognostic implications of cardiovascular magnetic resonance. Circ Cardiovasc Imaging 2009; 2: 243-250.
91. Abdel-Aty H, Simonetti O, Friedrich MG,. T2-weighted cardiovascular magnetic resonance imaging. J Magn Reson Imaging 2007; 26: 452-459. (Pubitemid 350194566)
92. Eitel I, Friedrich MG,. T2-weighted cardiovascular magnetic resonance in acute cardiac disease. J Cardiovasc Magn Reson 2011; 13: 13.
93. Higgins CB, Herfkens R, Lipton MJ, et al. Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: alterations in magnetic relaxation times. Am J Cardiol 1983; 52: 184-188. (Pubitemid 13061350)
94. Simonetti OP, Finn JP, White RD, Laub G, Henry DA,. "Black blood" T2-weighted inversion-recovery MR imaging of the heart. Radiology 1996; 199: 49-57.
95. Kellman P, Aletras AH, Mancini C, McVeigh ER, Arai AE,. T2-prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo. Magn Reson Med 2007; 57: 891-897. (Pubitemid 46709409)
96. Abdel-Aty H, Cocker M, Strohm O, Filipchuk N, Friedrich MG,. Abnormalities in T2-weighted cardiovascular magnetic resonance images of hypertrophic cardiomyopathy: regional distribution and relation to late gadolinium enhancement and severity of hypertrophy. J Magn Reson Imaging 2008; 28: 242-245. (Pubitemid 351956489)
97. Abdel-Aty H, Cocker M, Meek C, Tyberg JV, Friedrich MG,. Edema as a very early marker for acute myocardial ischemia: a cardiovascular magnetic resonance study. J Am Coll Cardiol 2009; 53: 1194-1201.
98. Schulz-Menger J, Gross M, Messroghli D, Uhlich F, Dietz R, Friedrich MG,. Cardiovascular magnetic resonance of acute myocardial infarction at a very early stage. J Am Coll Cardiol 2003; 42: 513-518. (Pubitemid 36951720)
99. Friedrich MG, Abdel-Aty H, Taylor A, Schulz-Menger J, Messroghli D, Dietz R,. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol 2008; 51: 1581-1587. (Pubitemid 351508364)
100. Francone M, Bucciarelli-Ducci C, Carbone I, et al. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance. J Am Coll Cardiol 2009; 54: 2145-2153.
101. Abdel-Aty H, Zagrosek A, Schulz-Menger J, et al. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 2004; 109: 2411-2416. (Pubitemid 38679560)
102. Nilsson JC, Nielsen G, Groenning BA, et al. Sustained postinfarction myocardial oedema in humans visualised by magnetic resonance imaging. Heart 2001; 85: 639-642. (Pubitemid 32973458)
103. Weinsaft JW, Kim HW, Shah DJ, et al. Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction. J Am Coll Cardiol 2008; 52: 148-157. (Pubitemid 351885445)
104. Mollet NR, Dymarkowski S, Volders W, et al. Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease. Circulation 2002; 106: 2873-2876. (Pubitemid 35424733)
105. Srichai MB, Junor C, Rodriguez LL, et al. Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. Am Heart J 2006; 152: 75-84. (Pubitemid 43974727)
106. Baer FM, Theissen P, Schneider CA, et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 1998; 31: 1040-1048. (Pubitemid 28212504)
107. Baer FM, Smolarz K, Jungehulsing M, et al. Chronic myocardial infarction: assessment of morphology, function, and perfusion by gradient echo magnetic resonance imaging and 99mTc-methoxyisobutyl-isonitrile SPECT. Am Heart J 1992; 123: 636-645.
108. Bove CM, DiMaria JM, Voros S, Conaway MR, Kramer CM,. Dobutamine response and myocardial infarct transmurality: functional improvement after coronary artery bypass grafting-initial experience. Radiology 2006; 240: 835-841. (Pubitemid 44267342)
109. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343: 1445-1453.
110. Selvanayagam JB, Kardos A, Francis JM, et al. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation 2004; 110: 1535-1541. (Pubitemid 39297973)
111. Wellnhofer E, Olariu A, Klein C, et al. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation 2004; 109: 2172-2174. (Pubitemid 38625392)
112. Kirschbaum SW, Rossi A, van Domburg RT, et al. Contractile reserve in segments with nontransmural infarction in chronic dysfunctional myocardium using low-dose dobutamine CMR. JACC Cardiovasc Imaging 2010; 3: 614-622.
113. Ichikawa Y, Sakuma H, Suzawa N, et al. Late gadolinium-enhanced magnetic resonance imaging in acute and chronic myocardial infarction. Improved prediction of regional myocardial contraction in the chronic state by measuring thickness of nonenhanced myocardium. J Am Coll Cardiol 2005; 45: 901-909. (Pubitemid 40342817)
114. Glaveckaite S, Valeviciene N, Palionis D, et al. Value of scar imaging and inotropic reserve combination for the prediction of segmental and global left ventricular functional recovery after revascularisation. J Cardiovasc Magn Reson 2011; 13: 35.
115. Kwong RY, Sattar H, Wu H, et al. Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation 2008; 118: 1011-1020.
116. Roes SD, Kelle S, Kaandorp TA, et al. Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction. Am J Cardiol 2007; 100: 930-936. (Pubitemid 47368098)
117. Kwon DH, Halley CM, Carrigan TP, et al. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. JACC Cardiovasc Imaging 2009; 2: 34-44.
118. Boye P, Abdel-Aty H, Zacharzowsky U, et al. Prediction of life-threatening arrhythmic events in patients with chronic myocardial infarction by contrast-enhanced CMR. JACC Cardiovasc Imaging 2011; 4: 871-879.
119. Roes SD, Borleffs CJ, van der Geest RJ, et al. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Circ Cardiovasc Imaging 2009; 2: 183-190.
120. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008; 117: e350-408. (Pubitemid 351771339)
121. Schelbert EB, Hsu LY, Anderson SA, et al. Late gadolinium-enhancement cardiac magnetic resonance identifies postinfarction myocardial fibrosis and the border zone at the near cellular level in ex vivo rat heart. Circ Cardiovasc Imaging 2010; 3: 743-752.
122. Eitel I, Desch S, Fuernau G, et al. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. J Am Coll Cardiol 2010; 55: 2470-2479.
123. Raman SV, Simonetti OP, Winner MW III, et al. Cardiac magnetic resonance with edema imaging identifies myocardium at risk and predicts worse outcome in patients with non-ST-segment elevation acute coronary syndrome. J Am Coll Cardiol 2010; 55: 2480-2488.
124. Ganame J, Messalli G, Dymarkowski S, et al. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. Eur Heart J 2009; 30: 1440-1449.
125. Mather AN, Fairbairn TA, Ball SG, Greenwood JP, Plein S,. Reperfusion haemorrhage as determined by cardiovascular MRI is a predictor of adverse left ventricular remodelling and markers of late arrhythmic risk. Heart 2011; 97: 453-459.
126. Bekkers SC, Yazdani SK, Virmani R, Waltenberger J,. Microvascular obstruction: underlying pathophysiology and clinical diagnosis. J Am Coll Cardiol 2010; 55: 1649-1660.
127. de Waha S, Desch S, Eitel I, et al. Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers. Eur Heart J 2010; 31: 2660-2668.
128. Nijveldt R, Beek AM, Hirsch A, et al. Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. J Am Coll Cardiol 2008; 52: 181-189. (Pubitemid 351915778)
129. Hombach V, Grebe O, Merkle N, et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 2005; 26: 549-557. (Pubitemid 40461096)
130. Larson DM, Menssen KM, Sharkey SW, et al. "False-positive" cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarction. JAMA 2007; 298: 2754-2760. (Pubitemid 350294298)
131. Flett AS, Hasleton J, Cook C, et al. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging 2011; 4: 150-156.
132. Mather AN, Fairbairn TA, Artis NJ, Greenwood JP, Plein S,. Timing of cardiovascular MR imaging after acute myocardial infarction: effect on estimates of infarct characteristics and prediction of late ventricular remodeling. Radiology 2011; 261: 116-126.
133. Wince WB, Kim RJ,. Molecular imaging: T2-weighted CMR of the area at risk-a risky business? Nat Rev Cardiol 2010; 7: 547-549.
134. Verhaert D, Thavendiranathan P, Giri S, et al. Direct t2 quantification of myocardial edema in acute ischemic injury. JACC Cardiovasc Imaging 2011; 4: 269-278.
135. Ogawa S, Lee TM, Kay AR, Tank DW,. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A 1990; 87: 9868-9872. (Pubitemid 120016545)
136. Friedrich MG, Niendorf T, Schulz-Menger J, Gross CM, Dietz R,. Blood oxygen level-dependent magnetic resonance imaging in patients with stress-induced angina. Circulation 2003; 108: 2219-2223. (Pubitemid 37363038)
137. Jahnke C, Gebker R, Manka R, Schnackenburg B, Fleck E, Paetsch I,. Navigator-gated 3D blood oxygen level-dependent CMR at 3.0-T for detection of stress-induced myocardial ischemic reactions. JACC Cardiovasc Imaging 2010; 3: 375-384.
138. Karamitsos TD, Leccisotti L, Arnold JR, et al. Relationship between regional myocardial oxygenation and perfusion in patients with coronary artery disease: insights from cardiovascular magnetic resonance and positron emission tomography. Circ Cardiovasc Imaging 2010; 3: 32-40.
139. Stuber M, Weiss RG,. Coronary magnetic resonance angiography. J Magn Reson Imaging 2007; 26: 219-234. (Pubitemid 47257719)
140. Kato S, Kitagawa K, Ishida N, et al. Assessment of coronary artery disease using magnetic resonance coronary angiography: a national multicenter trial. J Am Coll Cardiol 2010; 56: 983-991.
141. Hamdan A, Asbach P, Wellnhofer E, et al. A prospective study for comparison of MR and CT imaging for detection of coronary artery stenosis. JACC Cardiovasc Imaging 2011; 4: 50-61.
142. Botnar RM, Stuber M, Kissinger KV, Kim WY, Spuentrup E, Manning WJ,. Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging. Circulation 2000; 102: 2582-2587.
143. Hays AG, Hirsch GA, Kelle S, Gerstenblith G, Weiss RG, Stuber M,. Noninvasive visualization of coronary artery endothelial function in healthy subjects and in patients with coronary artery disease. J Am Coll Cardiol 2010; 56: 1657-1665.
144. Ibrahim T, Makowski MR, Jankauskas A, et al. Serial contrast-enhanced cardiac magnetic resonance imaging demonstrates regression of hyperenhancement within the coronary artery wall in patients after acute myocardial infarction. JACC Cardiovasc Imaging 2009; 2: 580-588.
145. Lin K, Lloyd-Jones DM, Liu Y, Bi X, Li D, Carr JC,. Noninvasive evaluation of coronary distensibility in older adults: a feasibility study with MR angiography. Radiology 2011; 261: 771-778.
146. Makowski MR, Wiethoff AJ, Blume U, et al. Assessment of atherosclerotic plaque burden with an elastin-specific magnetic resonance contrast agent. Nat Med 2011; 17: 383-388.
147. von Knobelsdorff-Brenkenhoff F, Frauenrath T, Prothmann M, et al. Cardiac chamber quantification using magnetic resonance imaging at 7 Tesla-a pilot study. Eur Radiol 2010; 20: 2844-2852.
148. van Elderen SG, Versluis MJ, Westenberg JJ, et al. Right coronary MR angiography at 7 T: a direct quantitative and qualitative comparison with 3 T in young healthy volunteers. Radiology 2010; 257: 254-259.
149. Wu MT, Su MY, Huang YL, et al. Sequential changes of myocardial microstructure in patients postmyocardial infarction by diffusion-tensor cardiac MR: correlation with left ventricular structure and function. Circ Cardiovasc Imaging 2009; 2: 32-40.
150. Sosnovik DE, Wang R, Dai G, Reese TG, Wedeen VJ,. Diffusion MR tractography of the heart. J Cardiovasc Magn Reson 2009; 11: 47.